Richmond Pharmacology and Trial4Us were referenced in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills.

The focus is on how clinical research organisations, such as Richmond Pharmacology, are encouraging volunteers to participate in crucial early phase clinical research and how their experience is tailored to ensure they are as comfortable as possible during the process. For example, providing access to super fast broadband to enable volunteers to continue to work from the unit, stream entertainment or access in-house entertainment such as Netflix, games and reading materials. We also have a concierge service to help with transport and accommodation options. The article also contains important safety and regulatory assurances for members of the public.

Richmond Pharmacology are sector leaders in the conduct of clinical trials in both healthy and patient populations. This is demonstrated though excellent feedback and high retention rates which are essential in the safe delivery of clinical studies.

Reflections from our recent trial participants are available to view here.

Latest news

Patient safety is not an afterthought. Explore our new infographic!

September 17, 2025
Patient safety is not an afterthought; it is the foundation of every clinical trial.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event